163 related articles for article (PubMed ID: 15090575)
1. Chronic inflammatory demyelinating polyneuropathy: decreased claudin-5 and relocated ZO-1.
Kanda T; Numata Y; Mizusawa H
J Neurol Neurosurg Psychiatry; 2004 May; 75(5):765-9. PubMed ID: 15090575
[TBL] [Abstract][Full Text] [Related]
2. Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP.
Sommer C; Koch S; Lammens M; Gabreels-Festen A; Stoll G; Toyka KV
Neurology; 2005 Dec; 65(12):1924-9. PubMed ID: 16380614
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy.
Bosboom WM; van den Berg LH; Franssen H; Giesbergen PC; Flach HZ; van Putten AM; Veldman H; Wokke JH
Brain; 2001 Dec; 124(Pt 12):2427-38. PubMed ID: 11701597
[TBL] [Abstract][Full Text] [Related]
4. N(epsilon)-Carboxymethyllysine in diabetic and non-diabetic polyneuropathies.
Haslbeck KM; Schleicher ED; Friess U; Kirchner A; Neundörfer B; Heuss D
Acta Neuropathol; 2002 Jul; 104(1):45-52. PubMed ID: 12070663
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic value of sural nerve T cells in chronic inflammatory demyelinating polyneuropathy.
Bosboom WM; Van den Berg LH; De Boer L; Van Son MJ; Veldman H; Franssen H; Logtenberg T; Wokke JH
Neurology; 1999 Sep; 53(4):837-45. PubMed ID: 10489051
[TBL] [Abstract][Full Text] [Related]
6. Cytokines in sural nerve biopsies from inflammatory and non-inflammatory neuropathies.
Lindenlaub T; Sommer C
Acta Neuropathol; 2003 Jun; 105(6):593-602. PubMed ID: 12734666
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological characteristics of subtypes of chronic inflammatory demyelinating polyradiculoneuropathy.
Ikeda S; Koike H; Nishi R; Kawagashira Y; Iijima M; Katsuno M; Sobue G
J Neurol Neurosurg Psychiatry; 2019 Sep; 90(9):988-996. PubMed ID: 31227562
[TBL] [Abstract][Full Text] [Related]
8. Myelin barrier breakdown, mechanical hypersensitivity, and painfulness in polyneuropathy with claudin-12 deficiency.
Chen JT; Hu X; Otto IUC; Schürger C; von Bieberstein BR; Doppler K; Krug SM; Hankir MK; Blasig R; Sommer C; Brack A; Blasig IE; Rittner HL
Neurobiol Dis; 2023 Sep; 185():106246. PubMed ID: 37527762
[TBL] [Abstract][Full Text] [Related]
9. Endoneurial edema in sural nerve may indicate recent onset inflammatory neuropathy.
Üçeyler N; Necula G; Wagemann E; Toyka KV; Sommer C
Muscle Nerve; 2016 May; 53(5):705-10. PubMed ID: 26439587
[TBL] [Abstract][Full Text] [Related]
10. Fingolimod promotes blood-nerve barrier properties in vitro.
Nishihara H; Maeda T; Sano Y; Ueno M; Okamoto N; Takeshita Y; Shimizu F; Koga M; Kanda T
Brain Behav; 2018 Apr; 8(4):e00924. PubMed ID: 29670818
[TBL] [Abstract][Full Text] [Related]
11. Glycosphingolipid antibodies and blood-nerve barrier in autoimmune demyelinative neuropathy.
Kanda T; Yamawaki M; Iwasaki T; Mizusawa H
Neurology; 2000 Apr; 54(7):1459-64. PubMed ID: 10751258
[TBL] [Abstract][Full Text] [Related]
12. Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies.
Koike H; Kadoya M; Kaida KI; Ikeda S; Kawagashira Y; Iijima M; Kato D; Ogata H; Yamasaki R; Matsukawa N; Kira JI; Katsuno M; Sobue G
J Neurol Neurosurg Psychiatry; 2017 Jun; 88(6):465-473. PubMed ID: 28073817
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory infiltrates in sural nerve biopsies in Guillain-Barre syndrome and chronic inflammatory demyelinating neuropathy.
Schmidt B; Toyka KV; Kiefer R; Full J; Hartung HP; Pollard J
Muscle Nerve; 1996 Apr; 19(4):474-87. PubMed ID: 8622727
[TBL] [Abstract][Full Text] [Related]
14. Claudin-1 and occludin expression in demyelinating peripheral neuropathies.
Manole E; Ceafalan LC; Oproiu AM; Popa-Wagner A; Popescu BO
Rom J Morphol Embryol; 2015; 56(3):1097-102. PubMed ID: 26662145
[TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulin is effective in patients with diabetes and with chronic inflammatory demyelinating polyneuropathy: long term follow-up.
Jann S; Bramerio MA; Facchetti D; Sterzi R
J Neurol Neurosurg Psychiatry; 2009 Jan; 80(1):70-3. PubMed ID: 18768571
[TBL] [Abstract][Full Text] [Related]
16. Severity and patterns of blood-nerve barrier breakdown in patients with chronic inflammatory demyelinating polyradiculoneuropathy: correlations with clinical subtypes.
Shimizu F; Sawai S; Sano Y; Beppu M; Misawa S; Nishihara H; Koga M; Kuwabara S; Kanda T
PLoS One; 2014; 9(8):e104205. PubMed ID: 25105500
[TBL] [Abstract][Full Text] [Related]
17. Sural nerve T-cell receptor Vbeta gene utilization in chronic inflammatory demyelinating polyneuropathy and vasculitic neuropathy.
Bosboom WM; Van den Berg LH; Mollee I; Sasker LD; Jansen J; Wokke JH; Logtenberg T
Neurology; 2001 Jan; 56(1):74-81. PubMed ID: 11148239
[TBL] [Abstract][Full Text] [Related]
18. Fibronectin connecting segment-1 peptide inhibits pathogenic leukocyte trafficking and inflammatory demyelination in experimental models of chronic inflammatory demyelinating polyradiculoneuropathy.
Dong C; Greathouse KM; Beacham RL; Palladino SP; Helton ES; Ubogu EE
Exp Neurol; 2017 Jun; 292():35-45. PubMed ID: 28215575
[TBL] [Abstract][Full Text] [Related]
19. Focal lesions area feature of chronic inflammatory demyelinating polyneuropathy (CIDP).
Rizzuto N; Morbin M; Cavallaro T; Ferrari S; Fallahi M; Galiazzo Rizzuto S
Acta Neuropathol; 1998 Dec; 96(6):603-9. PubMed ID: 9845290
[TBL] [Abstract][Full Text] [Related]
20. Peripheral nerve extracellular matrix remodeling in Charcot-Marie-Tooth type I disease.
Palumbo C; Massa R; Panico MB; Di Muzio A; Sinibaldi P; Bernardi G; Modesti A
Acta Neuropathol; 2002 Sep; 104(3):287-96. PubMed ID: 12172915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
